Abstract
Audits of the informed consent process are a key element of a clinical research quality assurance program. A systematic approach to such audits has not been described in the literature. In this paper we describe two components of the audit. The first is the audit of the informed consent document to verify adherence with federal regulations. The second component is comprised of the audit of the informed consent conference, with emphasis on a real time review of the appropriate communication of the key elements of the informed consent. Quality measures may include preparation of an informed consent history log, notes to accompany the informed consent, the use of an informed consent feedback tool, and the use of institutional surveys to assess comprehension of the informed consent process.
Similar content being viewed by others
References
Bankert, E., & Amdur, R. (2009). Informed conset feeback tool. In Institutional review board (2nd ed., Chapter 6–12, pp. 246–248). London, UK: Jones and Bartlett.
Barrett, R. (2005). Quality of informed consent: Measuring understanding among participants in oncology clinical trials. Oncology Nursing Forum, 32, 751–755.
Brehaut, J., Saginur, R., & Elwyn, G. (2009). Informed consent documentation: Necessary but not sufficient. Contemporary Clinical Trials, 30, 388–389.
Clark, S., Mangram, A., & Erenst, D. (2011). A study of the efficacy of informed consents and the associated role of language barriers. Journal of Surgical Education, 68, 143–147.
Cohn, E., Jia, H., & Erwin, K. (2011). Measuring the process and quality of De informed consent for clinical research development and testing. Oncology Nursing Forum, 38, 417–422.
Derse, A. (2007). Is patients’ time too valuable for informed consent? American Journal of Bioethics, 7, 45–46.
Fortun, P., West, J., & Chalkley, L. (2008). Recall of informed consent information by heathy volunteers in clinical trials. QJM, 10, 625–629.
Jaffe, S., Cook, E., & Cleary, P. (2001). Quality of informed consent: A new measure of understanding among research subjects. Journal of the National Cancer Institute, 93, 139–147.
Jansson, R. (2003). Researcher liability for negligence in human subject research: Informed consent and researcher malpractice claims. Washington Law Review, 78, 229–263.
Jefford, M., & Moore, R. (2008). Improvement of informed consent and the quality of consent documents. Lancet Oncology, 9, 485–493.
Kusec, S., Oreskovic, S., & Skegro, M. (2006). Improving comprehension of informed consent. Patient Education and Counseling, 60, 294–300.
Lad, P. M., & Dahl, R. (2013). An IRB-based clinical research quality assurance program. Accountability in Research, 20, 13–26.
Lansimies-Antikainen, H., & Laitinen, T. (2010). Evaluation of informed consent in health research: A questionnaire survey. Scandinavian Journal of Caring Sciences, 24, 56–64.
Lidz, C. (2006). The therapeutic misconception and our models of competency and informed consent. Behavioral Sciences and the Law, 24, 535–546.
Long, K. (2010). Informed consent in pediatric clinical trials: Giving adolescents a voice. Pediatric Blood & Cancer, 55, 8–9.
Maloney, D. (2002). Lawsuit claims that informed consent procedures did not follow regulations. Human Research Report, 17, 8.
Maloney, D. (2004). Numerous violations of federal informed consent. Human Research Report, 19, 1–3.
Melo-Martin, I., & Ho, A. (2008). Beyond informed consent: The therapeutic misconception and trust. Journal of Medical Ethics, 34, 202–205.
Messer, N. (2004). Professional patient relationship in informed consent. Postgraduate Medical Journal, 80, 277–283.
Resnik, D. (2009). Do informed consent documents matter? Contemporary Clinical Trials, 30, 114–115.
Shamoo, A. (1991a). Policies and quality assurance in the pharmaceutical industry. Accountability in Research, 1, 273–274.
Shamoo, A. (1991b). Quality assurance. Quality assurance, vol 1, pp. 4–9.
Shamoo, A., & Resnik, D. (2009). In Responsible conduct of research (2nd ed., pp. 58–61). New York: Oxford University Press.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lad, P.M., Dahl, R. Audit of the Informed Consent Process as a Part of a Clinical Research Quality Assurance Program. Sci Eng Ethics 20, 469–479 (2014). https://doi.org/10.1007/s11948-013-9461-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11948-013-9461-4